UCI president Brian Cookson has spoken publicly for the first time on Bradley Wiggins’ contentious use of the corticosteroid triamcinolone acetonide under a therapeutic use exemption, telling Cyclingnews that "no rules have been broken" and no action is likely to follow against the Briton.
Cookson was speaking ahead of the UCI Road World Championships in Doha on Saturday evening, more than three weeks after Russian cyber-hacking group Fancy Bears leaked information from the World Anti-Doping Agency database, which showed that Wiggins had been granted TUEs to receive 40mg injections of the powerful corticosteroid triamcinolone acetonide before the 2011 and 2012 Tours de France, and the 2013 Giro d’Italia. Wiggins won the Tour in 2012, becoming the first British rider to do so.
"We have no reason to believe any of those TUEs have been issued inappropriately. All of them have been entered on the ADAMS system so WADA have been able to review them at any time, as they can now," Cookson told Cyclingnews. "As far as I’m concerned, and unless I hear differently from WADA or the Cycling Anti-Doping Foundation, no rules have been broken and there’s no reason to assume that any action will follow."
ADVERTISEMENT
Wiggins and Sky have insisted that the injections were prescribed to treat asthma and pollen allergies, with team manager Dave Brailsford even claiming that he was unaware of the performance-enhancing properties of the corticosteroid.
Britain’s NHS has counselled its doctors against administering triamcinolone acetonide injections to treat hay fever except as a last resort in recent years, however, while former riders including David Millar and Michael Rasmussen have described how they had used the substance as a doping product during their careers. Cookson, however, appeared satisfied that procedures had been followed and that the case did not constitute an abuse of the TUE system.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2d3fwWd
No comments:
Post a Comment